441 related articles for article (PubMed ID: 12661516)
1. [Molecular mechanisms behind the immunological reaction against gluten in patients with celiac disease].
Nielsen C; Husby S; Lillevang ST
Ugeskr Laeger; 2003 Feb; 165(9):917-20. PubMed ID: 12661516
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the binding of gluten T-cell epitopes to various human leukocyte antigen class II molecules.
Bergseng E; Sidney J; Sette A; Sollid LM
Hum Immunol; 2008 Feb; 69(2):94-100. PubMed ID: 18361933
[TBL] [Abstract][Full Text] [Related]
3. T-cell response to gluten in patients with HLA-DQ2.2 reveals requirement of peptide-MHC stability in celiac disease.
Bodd M; Kim CY; Lundin KE; Sollid LM
Gastroenterology; 2012 Mar; 142(3):552-61. PubMed ID: 22108197
[TBL] [Abstract][Full Text] [Related]
4. The molecular basis of celiac disease.
Koning F
J Mol Recognit; 2003; 16(5):333-6. PubMed ID: 14523946
[TBL] [Abstract][Full Text] [Related]
5. The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses.
Vader W; Stepniak D; Kooy Y; Mearin L; Thompson A; van Rood JJ; Spaenij L; Koning F
Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12390-5. PubMed ID: 14530392
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and evaluation of high-affinity binders for the celiac disease associated HLA-DQ2 molecule.
Kapoerchan VV; Wiesner M; Hillaert U; Drijfhout JW; Overhand M; Alard P; van der Marel GA; Overkleeft HS; Koning F
Mol Immunol; 2010 Feb; 47(5):1091-7. PubMed ID: 19962195
[TBL] [Abstract][Full Text] [Related]
7. Coeliac disease: dissecting a complex inflammatory disorder.
Sollid LM
Nat Rev Immunol; 2002 Sep; 2(9):647-55. PubMed ID: 12209133
[TBL] [Abstract][Full Text] [Related]
8. [Disease mechanisms in coeliac disease].
Sollid LM; Lundin KE
Tidsskr Nor Laegeforen; 2003 Nov; 123(22):3230-3. PubMed ID: 14714017
[TBL] [Abstract][Full Text] [Related]
9. Celiac disease: caught between a rock and a hard place.
Koning F
Gastroenterology; 2005 Oct; 129(4):1294-301. PubMed ID: 16230082
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic variance in childhood coeliac disease and the HLA-DQ/DR dose effect.
Vermeulen BA; Hogen Esch CE; Yuksel Z; Koning F; Verduijn W; Doxiadis II; Schreuder GM; Mearin ML
Scand J Gastroenterol; 2009; 44(1):40-5. PubMed ID: 18932050
[TBL] [Abstract][Full Text] [Related]
11. A quantitative analysis of transglutaminase 2-mediated deamidation of gluten peptides: implications for the T-cell response in celiac disease.
Dørum S; Qiao SW; Sollid LM; Fleckenstein B
J Proteome Res; 2009 Apr; 8(4):1748-55. PubMed ID: 19239248
[TBL] [Abstract][Full Text] [Related]
12. Small-bowel mucosal transglutaminase 2-specific IgA deposits in coeliac disease without villous atrophy: a prospective and randomized clinical study.
Kaukinen K; Peräaho M; Collin P; Partanen J; Woolley N; Kaartinen T; Nuutinen T; Halttunen T; Mäki M; Korponay-Szabo I
Scand J Gastroenterol; 2005 May; 40(5):564-72. PubMed ID: 16036509
[TBL] [Abstract][Full Text] [Related]
13. Celiac disease: how complicated can it get?
Tjon JM; van Bergen J; Koning F
Immunogenetics; 2010 Oct; 62(10):641-51. PubMed ID: 20661732
[TBL] [Abstract][Full Text] [Related]
14. Transglutaminase 2-targeted autoantibodies in celiac disease: Pathogenetic players in addition to diagnostic tools?
Lindfors K; Mäki M; Kaukinen K
Autoimmun Rev; 2010 Sep; 9(11):744-9. PubMed ID: 20547248
[TBL] [Abstract][Full Text] [Related]
15. Evidence that HLA-DQ9 confers risk to celiac disease by presence of DQ9-restricted gluten-specific T cells.
Bodd M; Tollefsen S; Bergseng E; Lundin KE; Sollid LM
Hum Immunol; 2012 Apr; 73(4):376-81. PubMed ID: 22342873
[TBL] [Abstract][Full Text] [Related]
16. Celiac disease: from pathogenesis to novel therapies.
Schuppan D; Junker Y; Barisani D
Gastroenterology; 2009 Dec; 137(6):1912-33. PubMed ID: 19766641
[TBL] [Abstract][Full Text] [Related]
17. Modelling of HLA-DQ2 and its interaction with gluten peptides to explain molecular recognition in celiac disease.
Costantini S; Rossi M; Colonna G; Facchiano AM
J Mol Graph Model; 2005 Apr; 23(5):419-31. PubMed ID: 15781184
[TBL] [Abstract][Full Text] [Related]
18. Celiac disease: epidemiology, pathogenesis, diagnosis, and nutritional management.
Schuppan D; Dennis MD; Kelly CP
Nutr Clin Care; 2005; 8(2):54-69. PubMed ID: 16013224
[TBL] [Abstract][Full Text] [Related]
19. Resistance to celiac disease in humanized HLA-DR3-DQ2-transgenic mice expressing specific anti-gliadin CD4+ T cells.
de Kauwe AL; Chen Z; Anderson RP; Keech CL; Price JD; Wijburg O; Jackson DC; Ladhams J; Allison J; McCluskey J
J Immunol; 2009 Jun; 182(12):7440-50. PubMed ID: 19494267
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic significance of HLA-DQ typing in patients with previous coeliac disease diagnosis based on histology alone.
Kapitány A; Tóth L; Tumpek J; Csípo I; Sipos E; Woolley N; Partanen J; Szegedi G; Oláh E; Sipka S; Korponay-Szabó IR
Aliment Pharmacol Ther; 2006 Nov; 24(9):1395-402. PubMed ID: 17059521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]